Full-Time

Strategic Sourcing Engineer

Confirmed live in the last 24 hours

Element Biosciences

Element Biosciences

201-500 employees

Biotechnology firm specializing in DNA sequencing

Compensation Overview

$119k - $156k/yr

+ Stock Options + Bonus

Senior, Expert

San Diego, CA, USA

On-site role at headquarters in San Diego, CA.

Category
Process Engineering
Required Skills
NetSuite
CAD
AutoCAD
SAP Products
Oracle
Data Analysis
SolidWorks
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in engineering, technical operations, or a related technical discipline
  • 5–10 years of experience in life sciences with a focus in technical sourcing, process engineering, supplier quality, or procurement engineering
  • Solid understanding of end-to-end supply chain principles and best practices
  • Deep knowledge of product development lifecycles, Bill of Materials (BOM) structures, and supplier qualification processes
  • Demonstrated expertise in contract negotiation and supplier relationship management
  • Experience working with ERP systems such as NetSuite, SAP, or Oracle
  • Proficient in data analysis and reporting tools, including Microsoft Excel and PowerPoint
  • Experience with software tools such as AutoCAD, SolidWorks, etc.
  • Highly detail-oriented, well-organized, and analytical with strong problem-solving skills
  • Skilled in making data-driven decisions with a strong analytical mindset
  • Proven ability to succeed in fast-paced environment with rapidly shifting priorities
  • Effective communicator with the ability to influence and collaborate across departments
  • Willing and able to challenge assumptions and offer objective, unbiased perspectives
Responsibilities
  • Source complex engineering components and assemblies—including mechanical, fluidic, and optical systems—for next-generation sequencing platforms
  • Collaborate with R&D and Operations to drive supplier selection for direct and indirect materials, contract manufacturing, and services, during both New Production Introduction (NPI) and post-launch phases
  • Develop and implement sourcing strategies aligned with the technology roadmap, emphasizing cost efficiency, manufacturability, quality, optimized lead times, and risk mitigations
  • Understanding of technical drawings and specifications, such as CAD models and blueprints
  • Negotiate contracts to secure competitive pricing, favorable terms, and strategic supplier partnerships
  • Partner with Quality to ensure supplier compliance with relevant standards such as ISO 13485
  • Track and report supplier performance metrics; manage scorecards and implement corrective actions
  • Strengthen supply chain resilience by qualifying alternate sources
  • Maintain accurate sourcing documentation
  • Leverage market intelligence, benchmarking, and cost modeling to manage cost-of-goods-sold (COGS) targets across product lifecycle stages, supply risks, cost drivers, make-vs-buy decisions, and dual sourcing strategies
  • Conduct semi-annual business reviews with strategic suppliers to evaluate performance and strengthen partnerships
  • Provide clear, data-driven updates to internal stakeholders through presentations and reports

Element Biosciences focuses on next-generation sequencing (NGS) technology with its main product, the AVITI System, which offers high-quality sequencing at a low cost of $1 per million reads. This compact benchtop system is designed for various clients, including academic researchers and pharmaceutical companies, providing industry-leading accuracy and cost-effectiveness. The company stands out by forming partnerships with other biotech firms, like QIAGEN, to deliver complete NGS workflows and by offering the 2023 AVITI for All Grant, which provides free sequencing for diverse applications. Element Biosciences aims to make high-quality sequencing accessible to accelerate research in the biotechnology field.

Company Size

201-500

Company Stage

Series D

Total Funding

$678M

Headquarters

San Diego, California

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Partnerships with Revvity and IDT expand Element's reach in specialized medical applications.
  • $680 million funding and unicorn status highlight strong financial backing and growth potential.
  • AVITI System's cost-effectiveness makes it attractive to a wide range of laboratories.

What critics are saying

  • Competition from Illumina and startups may pressure market share and pricing strategies.
  • Rapid genomics advancements require continuous innovation to maintain competitive edge.
  • Scaling production and maintaining quality could impact customer satisfaction and reputation.

What makes Element Biosciences unique

  • Element Biosciences offers the AVITI System with dual flow cell layout for flexibility.
  • The AVITI LT model provides low-cost, low-throughput sequencing for broader accessibility.
  • LoopSeq technology enhances sequencing accuracy and reduces errors in the AVITI System.

Help us improve and share your feedback! Did you find this helpful?

Benefits

100% company-paid medical, dental, & vision coverage

Flexible spending & health savings accounts

Premier mental health care

401(k) with immediately vested 4% company match

Company-paid Life and AD&D insurance

Stock option grants

Flexible time off

10 paid annual holidays

8-weeks paid parental leave

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

2%
Element Biosciences
Jun 4th, 2025
Element Biosciences to Present at the 2025 Human Cell Atlas General Meeting

SAN DIEGO, CA (June 5, 2025) - Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced they will be presenting at the annual Human Cell Atlas (HCA) general meeting in Singapore as part of the company's ongoing commercial partnership with the consortium.

iGrow News
Apr 11th, 2025
Daicel Arbor Biosciences Launches 2025 AVITI for Agrigenomics Grant

Daicel Arbor Biosciences and Element Biosciences launch the 2025 AVITI for Agrigenomics Accelerator Grant.

MWBN
Apr 10th, 2025
Accelerating agrigenomics: Daicel Arbor Biosciences and Element Biosciences announce new grant opportunity

ANN ARBOR, Mich., April 10, 2025 /PRNewswire/ - Daicel Arbor Biosciences, a company that offers tools and services to accelerate genomics and synthetic biology research, in collaboration with Element Biosciences, a life sciences company democratizing access to advanced biological tools,...

Securities.io
Feb 24th, 2025
Illumina (Ilmn): Building The Picks And Shovels Of The Genomic Age

Genome Sequencing Cost CurveFor most of the history of medicine, doctors have been limited to observing symptoms and trying to alleviate them. This has been especially true for non-infectious diseases stemming from dysfunction in the body, including genetic diseases.With the discovery of DNA structure and function, awarded the 1962 Nobel Prize in Medicine , we started to have a better understanding of how the biological system truly works. PCR technology, awarded the 1993 Nobel Prize in Medicine , would open new ways to analyze it.This further expanded when full genomes started to be sequenced. The first human genome was sequenced in 2003 after 13 years of hard work, for a cost of $3B. Quickly, full-genome sequencing started to become cheaper and cheaper. By 2007, it would cost “only” $1M to sequence a full genome

HR Tech Wire
Feb 20th, 2025
Element Unveils AVITI24(TM) Innovation Roadmap Ahead of the Advances in Genome Biology and Technology (AGBT) 2025 Annual Meeting

Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced the Innovation Roadmap for AVITI24,(TM) the world's first natively paired spatial multiomic solution.